217 related articles for article (PubMed ID: 32332023)
21. Burden of non-tuberculous mycobacterial pulmonary disease in Germany.
Diel R; Jacob J; Lampenius N; Loebinger M; Nienhaus A; Rabe KF; Ringshausen FC
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446559
[TBL] [Abstract][Full Text] [Related]
22. Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis.
Eisenberg I; Yasin A; Fuks L; Stein N; Saliba W; Kramer MR; Adir Y; Shteinberg M
Lung; 2020 Aug; 198(4):715-722. PubMed ID: 32591896
[TBL] [Abstract][Full Text] [Related]
23. Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study.
Fujita K; Ito Y; Yamamoto Y; Kanai O; Imakita T; Oi I; Ito T; Saito Z; Mio T
BMC Pulm Med; 2022 Nov; 22(1):395. PubMed ID: 36329435
[TBL] [Abstract][Full Text] [Related]
24. [The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].
Sun YX; Shao C; Li S; Xu K; Huang H; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov; 42(11):826-831. PubMed ID: 31694092
[No Abstract] [Full Text] [Related]
25. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
Visser SK; Bye PTP; Fox GJ; Burr LD; Chang AB; Holmes-Liew CL; King P; Middleton PG; Maguire GP; Smith D; Thomson RM; Stroil-Salama E; Britton WJ; Morgan LC
Lung; 2019 Dec; 197(6):803-810. PubMed ID: 31691027
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.
Larsson LO; Polverino E; Hoefsloot W; Codecasa LR; Diel R; Jenkins SG; Loebinger MR
Expert Rev Respir Med; 2017 Dec; 11(12):977-989. PubMed ID: 28967797
[TBL] [Abstract][Full Text] [Related]
27. A retrospective observational study of antimicrobial treatment for non-tuberculous mycobacteria disease using a nationwide claims database in Japan.
Igari H; Yamagishi K; Yamazaki S; Murata S; Yahaba M; Takayanagi S; Kawasaki Y; Taniguchi T
J Infect Chemother; 2020 Apr; 26(4):349-352. PubMed ID: 31727566
[TBL] [Abstract][Full Text] [Related]
28. Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.
El-Zeenni N; Chanoine S; Recule C; Stahl JP; Maurin M; Camara B
Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):233-240. PubMed ID: 29067624
[TBL] [Abstract][Full Text] [Related]
29. A case-control study on the risk factors associated with the occurrence of non-tuberculous mycobacteria pulmonary disease in bronchiectasis patients.
Feng Y; Guo J; Luo S; Zhang Z
BMC Pulm Med; 2023 Nov; 23(1):451. PubMed ID: 37986162
[TBL] [Abstract][Full Text] [Related]
30. Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest.
Kwak N; Lee CH; Lee HJ; Kang YA; Lee JH; Han SK; Yim JJ
Eur Radiol; 2016 Dec; 26(12):4449-4456. PubMed ID: 26945763
[TBL] [Abstract][Full Text] [Related]
31. Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study.
Aliberti S; Sotgiu G; Castellotti P; Ferrarese M; Pancini L; Pasat A; Vanoni N; Spotti M; Mazzola E; Gramegna A; Saderi L; Perno CF; van Ingen J; Codecasa LR; Blasi F
Respir Med; 2020 Apr; 164():105899. PubMed ID: 32094101
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
[TBL] [Abstract][Full Text] [Related]
33. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
[TBL] [Abstract][Full Text] [Related]
34. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
Park S; Jo KW; Lee SD; Kim WS; Shim TS
Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
[TBL] [Abstract][Full Text] [Related]
36. Management of nontuberculous mycobacterial pulmonary disease.
Adelman MH; Addrizzo-Harris DJ
Curr Opin Pulm Med; 2018 May; 24(3):212-219. PubMed ID: 29470253
[TBL] [Abstract][Full Text] [Related]
37. Nontuberculous mycobacterial lung disease.
Griffith DE
Curr Opin Infect Dis; 2010 Apr; 23(2):185-90. PubMed ID: 20087178
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk.
Feng JY; Chen WC; Chen YY; Su WJ
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S23-S31. PubMed ID: 32482607
[TBL] [Abstract][Full Text] [Related]
39. Thoracoscopic management for bronchiectasis with non-tuberculous mycobacterial infection.
Wang GS; Wang Z; Yang L; Lin SL; Wu JS
Chin Med J (Engl); 2008 Dec; 121(24):2539-43. PubMed ID: 19187592
[TBL] [Abstract][Full Text] [Related]
40. Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey.
Lombardi A; Colaneri M; Sambo M; Di Matteo A; Sacchi P; Fabbiani M; Codecasa L; Aliberti S; Blasi F; Bandera A; Bruno R; Gori A
Respir Med; 2021 Apr; 179():106341. PubMed ID: 33618080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
